-
Acetylcysteine for Redox-Aware TNBC Assays
2026-09-12
Acetylcysteine can function as a mechanistic redox probe in triple-negative breast cancer nanotherapy assays, not merely as an antioxidant supplement. This guide explains how N-acetyl-L-cysteine can help separate photothermal injury, oxidative signaling, and immune-remodeling effects while preserving rigorous experimental interpretation.
-
Z-IETD-FMK Workflows for Caspase-8 Mapping
2026-09-11
Z-IETD-FMK enables targeted testing of caspase-8 dependence in activated T cells, death-receptor assays, and TRAIL responses. This workflow-focused guide shows how to separate upstream caspase-8 signaling from mitochondrial apoptosis, necroptosis, and nonspecific proliferation effects.
-
CSBTA Pharmacokinetics in MASH: Study Insights
2026-09-11
The reference study integrates plasma pharmacokinetics, tissue distribution, intracellular accumulation, and transporter or enzyme assays to explain why Corydalis saxicola Bunting total alkaloids behave differently in healthy and MASH-model mice. Its findings show that disease state and repeated dosing can increase exposure to key alkaloids, offering a mechanistic basis for more cautious dose-regimen design in MASLD/MASH research.
-
3-Methyladenine Workflow for Autophagy Research
2026-09-10
Use 3-Methyladenine as a mechanistic perturbation tool to test whether autophagy contributes to neuronal protection, axonal sprouting, tumor-cell survival, or migration phenotypes. This workflow combines time-resolved dosing, pathway controls, and orthogonal readouts so 3-MA results are not overinterpreted as proof of autophagy inhibition alone.
-
HLA-G+ EVTs in Maternal-Fetal Interaction Research
2026-09-10
Hamilton et al. present a practical protocol for isolating, culturing, and functionally testing HLA-G+ extravillous trophoblasts from distinct placental interfaces. The workflow connects primary fetal trophoblast biology with maternal leukocyte co-culture, enabling more reproducible studies of immune regulation at the maternal-fetal boundary.
-
EPI-001: Androgen Receptor N-Terminal Domain Inhibition
2026-09-09
EPI-001 is an androgen receptor N-terminal domain inhibitor designed to probe both ligand-dependent and ligand-independent AR signaling. This guide translates its mechanism into reproducible prostate cancer, CRPC, and exploratory AR/ARv7 assay workflows, with practical formulation and troubleshooting advice.
-
Pentoxifylline: Reading Cytokine Assays in Context
2026-09-09
Pentoxifylline is a phosphodiesterase inhibitor whose value in inflammation research depends on context, timing, cell type, and endpoint selection. This article interprets disease-informed cytokine evidence and translates it into better assay decisions across immune, infectious-disease, and translational models.
-
miRNA–mRNA Modules Drive Juvenile Hormone Biosynthesis
2026-09-08
Li and colleagues show that coordinated miRNA–mRNA regulation in the locust corpora allata supports the high juvenile hormone output required for vitellogenesis and egg production. The study combines transcriptomics, expression validation, reporter assays, and agomiR perturbation to connect post-transcriptional control with vitellogenin expression and ovarian development.
-
Cy3 RNA Labeling Kit: Practical T7 Workflow
2026-09-08
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro synthesis of randomly Cy3-modified RNA probes for fluorescence-based RNA detection, including in situ hybridization and Northern blot workflows. It is intended for research use only and should not be used for diagnostic, therapeutic, or clinical applications.
-
HOTAIR–miR-30a-5p/PDE7A Axis in LPS-Induced ARDS
2026-09-07
The reference study links HOTAIR knockdown with reduced LPS-induced inflammatory injury through a miR-30a-5p/PDE7A regulatory axis. Its combined cell, reporter-assay, protein, and mouse-model evidence provides a useful mechanistic framework for studying lncRNA-regulated inflammation, while also highlighting the importance of controlled RNA template reverse transcription for expression analysis.
-
ETS1–SENP2–HSPA8 Axis in BPD Mitophagy
2026-09-05
The reference study identifies ETS1 as a transcriptional regulator that protects against hyperoxia-induced bronchopulmonary dysplasia by activating SENP2 and coordinating HSPA8-dependent FUNDC1 degradation. Its main innovation is linking transcriptional control, FUNDC1 SUMO1 modification, and chaperone-mediated disposal of a mitophagy receptor, providing a mechanistic framework for mitochondrial quality-control research in developing lung tissue.
-
HOBt in Medicinal Chemistry: Coupling to SAR
2026-09-05
HOBt (1-Hydroxybenzotriazole) is more than a racemization inhibitor: it can serve as a route-control element in stereochemically sensitive amide bond formation. This article connects HOBt hydration, coupling design, and interpretation of an indazole glucagon receptor antagonist study.
-
DiD (DiDC 18 (5)) Membrane Staining
2026-09-04
This scenario-based guide explains how DiD (DiDC 18 (5)) Plasma Membrane Red Fluorescent Probe, SKU B8805, can strengthen membrane labeling, cell tracking, immunofluorescence, and orthogonal viability workflows. It covers spectral selection, fixation, solvent handling, data interpretation, and practical vendor evaluation without treating membrane fluorescence as a standalone viability measurement.
-
Hoechst 33342 for Mechanistic Cell Assays
2026-09-04
Hoechst 33342 is more than a nuclear stain: it can anchor quantitative cell-state measurements within receptor, inflammatory, and barrier-function studies. This guide explains how to interpret its DNA signal alongside the causal evidence from a recent GERD study without overclaiming what nuclear fluorescence can prove.
-
Olsalazine Sodium: A Structure-to-Assay Framework
2026-09-03
Olsalazine Sodium is a mesalamine dimer that links LTB4-directed inflammation research with colorectal cancer tumor models and emerging xenobiotic-clearance assays. This article develops a structure-to-assay framework for separating chemical effects, transporter expression, and biological outcomes.